Author name: Leonardo Arias

The financing comes 11 months after Cornerstone raised $70 million to support the launch of its device in China.

Speaking at a conference this morning, Pfizer CEO Albert Bourla suggested that Metsera’s therapies could begin hitting the market in 2028.

The pandemic-era virtual care policies are back in place through Jan. 30. But short-term deals aren’t sustainable, telehealth advocates and providers say.

Only 41% of rural hospitals in the U.S. deliver babies, according to a report by the Center for Healthcare Quality and Payment Reform. In some states, fewer than one-third of these facilities offer labor and delivery services.

The House passed a stopgap funding bill and President Donald Trump signed it late Wednesday, reopening the government without a clear path forward on preserving enhanced subsidies for ACA plans — Democrats’ chief demand.

The decision is a “natural next step in our journey to becoming a fully independent company,” Siemens Healthineers CEO Bernd Montag said.

Korro Bio is moving back to square one as a preclinical biotech after the failure of KRRO-110 in alpha-1 antitrypsin deficiency. The company’s stock is down 80% on all the news.

Unpredictable communication and a lack of transparency are eroding the industry’s and the public’s trust. The FDA, experts agree, needs to take control of the narrative.

The House passed a stopgap funding bill and President Donald Trump signed it late Wednesday, reopening the government without a clear path forward on preserving enhanced subsidies for ACA plans — Democrats’ chief demand.

The plausible mechanism pathway “could accelerate gene therapy/editing development,” analysts at William Blair said Thursday, while adding that additional clarity is needed.